Pfizer Inc, multinational pharmaceutical corporation is producing the COVID-19 vaccine amid the surge of pandemic. The worst-hit country, India was recently decided to import foreign vaccine after daily COVID cases making new records. Pfizer told the Indian government that there was no concern over the safety of its Covid-19 vaccine on Monday. Pfizer producing the vaccine with German partner BioNTech SE, reiterated that it would supply doses only through government contracts.

The pharmaceutical corporation said that as the country insists on small local trials for foreign shots despite a record surge in infections and shortage of doses ‘we don’t guarantee safety.’ The government in mid-April made it easier for foreign vaccines approved in the West and Japan to sell in India. The Indian companies would still have to initiate a local clinical trial within 30 days of receiving emergency use authorization as a safety concern because there is no assurance of how it will react to Indian citizens. Previously, companies were required to do the trial prior to approval. India has invited Pfizer, Johnson & Johnson and Moderna Inc to sell their vaccines to the country but none have applied to do so yet. However, Pfizer is holding fresh talks with the government after having withdrawn its initial application in February for emergency use authorization was supported with data that shows an overall efficacy rate of 95% with no safety concerns.

The vaccine’s storage requires ultra-low temperature that is minus 70 degrees Celsius (-90 F). Pfizer said the company could deliver the shot to vaccination centers using its specially designed, temperature-controlled thermal shippers.

Also Read

On board Air India Amritsar-Rome flight passenger found COVID-positive

What's in your zodiac sign stars today, here's your horoscope

Bill Gates, wife Melinda to take divorce after 27 years of marriage